1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Boston Scientific Acquires Axonics

Add-on Acquisition • Medical Products

Boston Scientific Acquires Axonics

On January 8, 2024, Boston Scientific acquired medical products company Axonics for 3.7B USD

Acquisition Context
  • This is Boston Scientific’s 48th transaction in the Medical Products sector.
  • This is Boston Scientific’s 3rd largest (disclosed) transaction.
  • This is Boston Scientific’s 48th transaction in the United States.
  • This is Boston Scientific’s 25th transaction in California.

Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free


M&A Deal Summary
Date January 8, 2024
Target Axonics
Sector Medical Products
Buyer(s) Boston Scientific
Deal Type Add-on Acquisition
Deal Value 3.7B USD

Target Company

Axonics

Irvine, California, United States
Axonics is focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction. The Axonics product portfolio includes the Axonics R20TM and the Axonics F15TM Systems used to deliver sacral neuromodulation (SNM) therapy. SNM therapy is a minimally invasive procedure used in the treatment of OAB and fecal incontinence. It works by delivering mild electrical pulses to the sacral nerve to restore communication between the brain and the bladder. Axonics was founded in 2013 and is headquartered in Irvine, California.
Explore More Deals

Browse All 215,130 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Boston Scientific

Marlborough, Massachusetts, United States
Category Company
Founded 1979
Sector Medical Products
Employees48,000
Revenue 16.7B USD (2024)
DESCRIPTION
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.

Boston Scientific is a medical technology company that offers products and technologies used to diagnose and treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.

Deal Context for Buyer #
Overall 63 of 70
Sector: Medical Products 48 of 53
Type: Add-on Acquisition 49 of 54
State: California 25 of 29
Country: United States 48 of 55
Year: 2024 1 of 4
Size (of disclosed) 3 of 36
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-09-18 Relievant Medsystems

Edina, Minnesota, United States

Relievant Medsystems is a private, clinical-stage medical device company that is developing a novel treatment for chronic low back pain. The company's Intercept product, currently under development, is a minimally invasive system that allows a spine surgeon to target low back pain by ablating a nerve target within the vertebral body. Relievant Medsystems was formed in 2004 and is based in Edina, Minnesota.

Buy $850M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-06-18 Silk Road Medical

Sunnyvale, California, United States

Silk Road Medical is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Silk Road Medial was formed in 2007 and is based in Sunnyvale, California.

Buy $1.3B

Explore Related M&A Activity

Medical Products M&A - Add-on Acquisition M&A Deals - California M&A - United States M&A - 2024 M&A

Mergr

Solution for

Product

Company

Legal